NDC 0378-9072-16 - Rivastigmine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-9072
- Requested NDC
- 0378-9072-16
- Package NDCs from labels
- 0378-9072-16, 0378-9072-93
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2024-09-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rivastigmine - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2024-09-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0378-9072-16 | Rivastigmine | 24 h in 1 PATCH | PATCH | 24 | 10 | |
| 0378-9072-16 | Rivastigmine | 1 in 1 POUCH | PATCH | 1 | 10 | |
| 0378-9072-93 | Rivastigmine | 30 in 1 CARTON | PATCH | 30 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-9072-16 | EA - Each | 0378-9072 | abb14a85-0014-4176-935c-4e32e0f78262 | 1 | 2019-10-07 |
| 0378-9072-93 | EA - Each | 0378-9072 | 666f3027-9917-4851-a6ae-0da8e40b47a5 | 1 | 2018-07-03 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener | DOCUSATE SODIUM | Sam's West, Inc | b14d2495-1092-4063-869f-73a7e8c28708 | 2024-05-21 | Warnings | F05Q2T2JA0 |
| Stool Softener Plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Safeway, Inc. | 6bc9ea37-31b8-4a6d-9b2d-2c80bad4f30d | 2024-05-15 | Warnings | F05Q2T2JA0 |
| Stool Softener Plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Safeway, Inc. | c0898583-4bbb-41d5-9e84-00cca823024f | 2024-05-15 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM SENNOSIDES | QUALITY CHOICE (Chain Drug Marketing Association) | 9c986ca8-d540-49c1-b092-94c1bf837c07 | 2024-05-09 | Warnings | F05Q2T2JA0 |
| Rivastigmine | RIVASTIGMINE | Sandoz Inc | 92a58ebb-748d-49f4-bf11-ecbcf5424152 | 2024-05-08 | Warnings, Adverse reactions | 725021 1308569 725023 PKI06M3IW0 |
| Exelon | RIVASTIGMINE | Novartis Pharmaceuticals Corporation | 07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0 | 2024-05-08 | Warnings, Adverse reactions | 725021 1308569 725023 PKI06M3IW0 |
| Exelon | RIVASTIGMINE | Sandoz Inc | b6ed6d15-116d-4596-92ce-3414574d7ba0 | 2024-05-08 | Warnings, Adverse reactions | 725021 1308569 725023 PKI06M3IW0 |
| Docusate Sodium | DOCUSATE SODIUM | NuCare Pharmaceuticals,Inc. | ed20d198-e935-200e-e053-2a95a90a309b | 2024-05-02 | Warnings | F05Q2T2JA0 |
| Sennosides, Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Major Pharmaceuticals | 1768b470-2808-fa46-e063-6394a90ac8d9 | 2024-05-01 | Warnings | F05Q2T2JA0 |
| Stool Softener Stimulant laxative | DOCUSATE SODIUM AND SENNOSIDES | QUALITY CHOICE (Chain Drug Marketing Association) | 9467e1f7-19bb-4fb3-853b-75c4d28bb9a9 | 2024-05-01 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | QUALITY CHOICE (Chain Drug Marketing Association) | 72f8e8d7-ee38-4bd3-8711-f11fded0cede | 2024-05-01 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative Extra Strength | DOCUSATE SODIUM | P & L Development, LLC | c1e9863a-c229-4694-b450-6b0e0ad37503 | 2024-04-30 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | QUALITY CHOICE (Chain Drug Marketing Association) | 96c7f8bc-be95-40d1-9977-44b7cc6582df | 2024-04-22 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | H E B | 2f9e2723-53a7-47a8-8c41-87bffc4e50dd | 2024-04-09 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | H E B | 5b8bcc6c-de03-4d73-a76f-6f4c371cf250 | 2024-04-09 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | H E B | 1dd2be7e-bdca-4e43-b853-3ed10b636632 | 2024-04-08 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | Bryant Ranch Prepack | 1f11cf85-b094-4ca4-8b48-2d3a9093304b | 2024-04-04 | Warnings | F05Q2T2JA0 |
| SENNA-PLUS | SENNOSIDES AND DOCUSATE SODIUM | Bryant Ranch Prepack | 7f8396e7-07f0-4c9c-be8a-9dc00139cb83 | 2024-04-04 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | TARGET Corporation | 89106733-69f1-469b-9d07-f06ac09b2fb6 | 2024-04-02 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative Plus Stimulant | DOCUSATE SODIUM AND SENNOSIDES | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 89dc2063-6744-4412-89be-90990090b57c | 2024-03-19 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.